Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 3981 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Barinthus Biotherapeutics plc

Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Kane Biotech Inc.

RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  RespireRx Pharmaceuticals Inc.

Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ, Sets Sights on Expansion Into Costa Rica and Central America

Read more ››
By: GlobeNewswire - 20 Mar 2024

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Beyond Air, Inc.

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Col

Read more ››
By: GlobeNewswire - 20 Mar 2024

TFF Pharmaceuticals Announces Update on Clinical Programs

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  TFF Pharmaceuticals, Inc.

Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Celularity Inc.

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  AIM ImmunoTech Inc.

Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Nurix Therapeutics, Inc.

Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Immix Biopharma, Inc.

XTL To Aquire The Social Proxy

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  XTL Biopharmaceuticals Ltd.

Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  PharmAla Biotech

Decisions taken by Orion Corporation’s Annual General Meeting on 20 March 2024

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Orion Oyj

COVID Origin Is a Gordian Knot, according to the Journal of American Physicians and Surgeons

Read more ››
By: GlobeNewswire - 20 Mar 2024

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed

Read more ››
By: GlobeNewswire - 20 Mar 2024

Orion Corporation: Organising meeting of the Board of Directors

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Orion Oyj

SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT AND PROVIDES TRADING UPDATE

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  Sequana Medical NV

DAS Health Expands Presence with New Chicago Office Location

Read more ››
By: GlobeNewswire - 20 Mar 2024

TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 20 Mar 2024
Related companies:  TFF Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑